Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-24 Purchase | 2022-10-26 8:01 pm | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 800,000 | $17 | $13,600,000 | 6,128,297 (Indirect) | View |
| 2021-07-30 Purchase | 2021-08-03 9:06 pm | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,600,000 | $10 | $16,000,000 | 4,500,000 (Indirect Direct) | View |
| 2020-09-18 Purchase | 2020-09-22 11:09 am | Metacrine Inc. | MTCR | Burow Kristina Director | 230,000 | $13 | $2,990,000 | 158,734 (Indirect) | View |
| 2019-10-16 Purchase | 2019-10-18 7:58 pm | Vir Biotechnology Inc. | VIR | Burow Kristina Director | 1,000,000 | $20 | $20,000,000 | 1,000,000 (Indirect) | View |
| 2019-02-22 Purchase | 2019-02-26 9:03 pm | Sienna Biopharmaceuticals Inc. | SNNA | Burow Kristina Director | 2,165,800 | $2.5 | $5,414,500 | 1,865,800 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-24 Conversion | 2022-10-26 8:01 pm | N/A N/A | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 41,344,576 | $0 | 6,128,297 (Indirect) | View |
Ownership | 2022-10-19 8:08 pm | N/A N/A | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 11,456,594 (Indirect) | View |
| 2022-09-01 Option Award | 2022-09-02 4:06 pm | N/A 2032-09-01 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 10,391 | $0 | 10,391 (Direct) | View |
| 2022-06-09 Option Award | 2022-07-15 5:21 pm | N/A 2032-06-08 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:32 pm | N/A 2032-05-26 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2021-08-05 Other | 2021-08-09 8:31 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN Member of 10% owner group 10% Owner | 701,250 | $0 | 4,465,000 (Indirect) | View |
| 2021-07-30 Other | 2021-08-03 9:06 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 650,000 | $10 | 4,500,000 (Indirect) | View |
Ownership | 2021-07-27 9:58 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 5,166,250 (Indirect) | View |
| 2021-07-20 Conversion | 2021-07-20 8:53 pm | N/A N/A | Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 18,794,443 | $0 | 5,527,777 (Indirect) | View |
Ownership | 2021-07-15 9:06 pm | N/A N/A | Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 11,055,554 (Indirect) | View |
| 2021-06-30 Other | 2021-07-02 5:20 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 202,011 | $0 | 3,335,597 (Indirect) | View |
| 2021-06-25 Other | 2021-06-29 5:20 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 404,022 | $0 | 3,935,597 (Indirect) | View |
| 2021-06-24 Option Award | 2021-06-28 5:12 pm | N/A 2031-06-23 | Unity Biotechnology Inc. | UBX | Burow Kristina Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-21 Conversion | 2021-06-23 4:29 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 25,739,146 | $0 | 1,254,405 (Indirect) | View |
Ownership | 2021-06-16 7:35 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners X LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 2,508,809 (Indirect) | View |
| 2021-06-10 Option Award | 2021-06-14 07:55 am | N/A 2031-06-10 | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 6,877 | $0 | 6,877 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-10 9:01 pm | N/A 2031-06-08 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 5:03 pm | N/A 2031-05-27 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director | 7,800 | $0 | 7,800 (Direct) | View |
| 2021-05-24 Option Award | 2021-05-25 6:58 pm | N/A 2031-05-23 | Metacrine Inc. | MTCR | Burow Kristina Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-03-31 Other | 2021-04-02 3:21 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 202,011 | $0 | 3,929,564 (Indirect) | View |
| 2021-03-18 Other | 2021-03-22 7:37 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 404,023 | $0 | 4,529,565 (Indirect) | View |
| 2021-02-08 Conversion | 2021-02-10 7:22 pm | N/A N/A | Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner | 65,625,000 | $0 | 11,718,750 (Indirect) | View |
Ownership | 2021-02-03 9:30 pm | N/A N/A | Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 44,042,500 (Indirect) | View |
| 2020-05-21 Option Award(A) | 2020-10-13 7:08 pm | 2021-05-21 2030-05-20 | Vir Biotechnology Inc. | VIR | Burow Kristina Director | 25,404 | $0 | 25,404 (Direct) | View |
| 2020-09-18 Conversion | 2020-09-22 11:09 am | N/A N/A | Metacrine Inc. | MTCR | Burow Kristina Director | 2,710,503 | $0 | 158,734 (Indirect) | View |
Ownership | 2020-09-15 5:03 pm | N/A N/A | Metacrine Inc. | MTCR | Burow Kristina Director | 0 | $0 | 2,710,503 (Indirect) | View |
| 2020-06-18 Option Award | 2020-06-22 5:30 pm | N/A 2030-06-17 | Unity Biotechnology Inc. | UBX | Burow Kristina Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 4:55 pm | N/A 2030-06-16 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 4:38 pm | N/A 2030-06-16 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director 10% Owner | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-26 5:00 pm | 2021-05-21 2030-05-21 | Vir Biotechnology Inc. | VIR | Burow Kristina Director | 28,888 | $0 | 28,888 (Direct) | View |
| 2020-02-10 Conversion | 2020-02-11 09:04 am | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 16,486,078 | $0 | 4,121,519 (Indirect) | View |
Ownership | 2020-02-05 7:28 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burow Kristina Director | 0 | $0 | 8,243,039 (Indirect) | View |
| 2019-10-16 Conversion | 2019-10-18 7:58 pm | N/A N/A | Vir Biotechnology Inc. | VIR | Burow Kristina Director | 54,444,438 | $0 | 1,000,000 (Indirect) | View |
Ownership | 2019-10-10 7:12 pm | N/A N/A | Vir Biotechnology Inc. | VIR | Burow Kristina Director | 0 | $0 | 27,666,663 (Indirect) | View |
| 2019-06-20 Option Award | 2019-06-24 5:28 pm | N/A 2029-06-19 | Unity Biotechnology Inc. | UBX | Burow Kristina Director | 25,000 | $0 | 10,186,175 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-11 6:32 pm | N/A 2029-06-09 | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2019-05-30 Option Award | 2019-06-03 7:41 pm | N/A 2029-05-30 | Sienna Biopharmaceuticals Inc. | SNNA | Burow Kristina Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-23 9:43 pm | N/A 2029-05-21 | Scholar Rock Holding Corp | SRRK | Burow Kristina Director 10% Owner | 10,158 | $0 | 10,158 (Direct) | View |
| 2019-02-12 Conversion | 2019-02-12 5:44 pm | N/A N/A | Gossamer Bio Inc. | GOSS | Burow Kristina Director | 40,279,591 | $0 | 4,027,958 (Indirect) | View |